Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 14, 2018

Conditions
Lung Cancer
Interventions
RADIATION

SBRT

SBRT delivered in 3 fractions of 20 Gy/fraction over 1.5 to 2 weeks for a total of 60 Gy

Trial Locations (19)

10016

NYU Cancer Institute at New York University Medical Center, New York

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

22304

INOVA Alexandria Hospital, Alexandria

35294

UAB Comprehensive Cancer Center, Birmingham

46601

Memorial Hospital of South Bend, South Bend

48073

William Beaumont Hospital - Royal Oak Campus, Royal Oak

49503

Lacks Cancer Center at Saint Mary's Health Care, Grand Rapids

53226

Medical College of Wisconsin Cancer Center, Milwaukee

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

94704

Alta Bates Summit Comprehensive Cancer Center, Berkeley

94904

Marin Cancer Institute at Marin General Hospital, Greenbrae

95608

Mercy Cancer Center at Mercy San Juan Medical Center, Carmichael

95817

University of California Davis Cancer Center, Sacramento

98225

St. Joseph Cancer Center, Bellingham

40536-0093

Lucille P. Markey Cancer Center at University of Kentucky, Lexington

11794-9446

Stony Brook University Cancer Center, Stony Brook

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK

NCT00551369 - Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | Biotech Hunter | Biotech Hunter